GGrantIndex
Sort

82,697 grants matching vaccine development

Pandemic influenza DNA vaccine Development

$2,090,882
Lawrence R Smith · Vical, Inc. · U01 · FY2009 · AI

Expansion of antigen-specific T cells using programmable biomaterials for adoptive cellular therapy

$2,090,715
Catherine Ju-Ying Wu · Harvard University · U54 · FY2019 · CA

Genetic screens for key transcriptional regulators of antiviral T cell immunity

$2,090,598
Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2016 · AI

Genetic screens for key transcriptional regulators of antiviral T cell immunity

$2,090,598
Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2017 · AI

HIV Vaccine Design and Development Team

$2,090,481
Progenics Pharmaceuticals, Inc. · R01 · FY2001 · AI

University of Washington (UW) Sexually Transmitted Infections (STI) Cooperative Research Center (CRC) - Syphilis Vaccine to Protect against Local and Disseminated T. pallidum Infection

$2,090,181
Anna Wald · University Of Washington · U19 · FY2020 · AI

Computational Biology Core

$2,090,071
Bette T. Korb · Duke University · U19 · FY2010 · AI

Genetic screens for key transcriptional regulators of antiviral T cell immunity

$2,089,932
Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2014 · AI

Strategies for Cancer Immunotherapy Development: Preclinical Studies

$2,088,156
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Integrating innate and adaptive pathways in vaccine responses

$2,088,086
Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2019 · AI

Integrating innate and adaptive pathways in vaccine responses

$2,087,906
Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2020 · AI

Duke SPORE in Brain Cancer

$2,087,874
John H Sampson · Duke University · P50 · FY2019 · CA

Immunopathogenesis of Acute HIV-1 Infection

$2,087,864
Elizabeth Connick · University Of Colorado Denver · P01 · FY2007 · AI

Duke SPORE in Brain Cancer

$2,087,855
David M. Ashley · Duke University · P50 · FY2023 · CA

CLINICAL AND LABORATORY STUDIES OF MALIGNANT LYMPHOMAS

$2,087,820
Stanford University · P01 · FY2002 · CA

Native-like Envelope Trimer Therapeutic Vaccination for Induction of Broadly Neutralizing Antibodies to Facilitate HIV Functional Cure

$2,087,709
Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · AI

Philadelphia IMPAACT Clinical Trials Unit

$2,087,680
Steven Daniel Douglas · Children'S Hosp Of Philadelphia · U01 · FY2010 · AI

Integrating innate and adaptive pathways in vaccine responses

$2,087,668
Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2021 · AI

Integrating innate and adaptive pathways in vaccine responses

$2,087,498
Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2022 · AI

Integrating innate and adaptive pathways in vaccine responses

$2,087,423
Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2023 · AI

Mathematical Oncology Systems Analysis Imaging Center (MOSAIC)

$2,086,730
Kristin R Swanson · Mayo Clinic Arizona · U54 · FY2023 · CA

Duke SPORE in Brain Cancer

$2,086,695
David M. Ashley · Duke University · P50 · FY2022 · CA

Manufacturing and Regulatory Support of Ad/MVA and Ad/Protein HIV-1 Vaccines

$2,086,176
Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2012 · AI

Epithelial Ovarian Cancer Program Project

$2,085,988
David R Spriggs · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA

Tulane National Primate Research Center U24 AIDS SPF Breeding Colony Maintenance

$2,085,759
Rudolf P Bohm · Tulane University Of Louisiana · U24 · FY2014 · OD